|
|
|
|
| LEADER |
03087nam a2200469 4500 |
| 001 |
on1090060781 |
| 003 |
OCoLC |
| 005 |
20200326101200.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
190318s2019 ne ob 000 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d OPELS
|d N$T
|d DKU
|d UKMGB
|d UKAHL
|d OCLCF
|d GrThAP
|
| 015 |
|
|
|a GBB933899
|2 bnb
|
| 016 |
7 |
|
|a 019260313
|2 Uk
|
| 020 |
|
|
|a 9780444642783
|q (electronic bk.)
|
| 020 |
|
|
|a 0444642781
|q (electronic bk.)
|
| 020 |
|
|
|a 9780444642776
|
| 020 |
|
|
|a 0444642773
|
| 035 |
|
|
|a (OCoLC)1090060781
|
| 050 |
|
4 |
|a RS403
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.19
|2 23
|
| 245 |
0 |
0 |
|a Progress in medicinal chemistry.
|n Volume 58 /
|c edited by David R. Witty and Brian Cox.
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a Amsterdam :
|b Elsevier,
|c 2019.
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a Progress in Medicinal Chemistry
|v Volume 58
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
0 |
|t Preface /
|r David R. Witty, Brian Cox --
|g 1.
|t Covalent binders in drug discovery /
|r Anil Vasudevan, Maria A. Argiriadi, Aleksandra Baranczak, Michael M. Friedman, Julia Gavrilyuk, Adrian D. Hobson, Jonathan J. Hulce, Sami Osman, Noel S. Wilson --
|g 2.
|t Amyotrophic lateral sclerosis /
|r Klara Valko, Lukasz Ciesla --
|g 3.
|t Rewriting the (tran)script : application to spinal muscular atrophy /
|r Hasane Ratni, Lutz Mueller, Martin Ebeling --
|g 4.
|t Natural product drug delivery : a special challenge? /
|r Neil J. Press, Emilie Joly, Peter Ertl.
|
| 520 |
|
|
|a 'Progress in Medicinal Chemistry, Volume 58,' provides a review of eclectic developments in medicinal chemistry, with each chapter written by an international board of authors. Topics covered in this new release include Amyotrophic lateral sclerosis (ALS), Covalent-binding Drugs, Natural Product Drug Delivery - A Special Challenge?, and SMN2 gene splicing modifier, and more. Key Features: Provides extended, timely reviews of topics in medicinal chemistry; Contains targets and technologies relevant to the discovery of tomorrow's drugs; Presents analyses of successful drug discovery programs. Readership: Everyone interested in the strategy and practice of the preclinical phases of the creation of new medicines. Those wishing to understand the drivers of drug design or expand their knowledge of therapeutic target classes. --
|c Provided by publisher.
|
| 650 |
|
0 |
|a Pharmaceutical chemistry.
|
| 650 |
|
7 |
|a MEDICAL / Pharmacology
|2 bisacsh
|
| 650 |
|
7 |
|a Pharmaceutical chemistry.
|2 fast
|0 (OCoLC)fst01060115
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Witty, D. R.
|q (David R.),
|e editor.
|
| 700 |
1 |
|
|a Cox, Brian
|c (Chemist),
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Progress in medicinal chemistry. Volume 58.
|d Amsterdam : Elsevier, 2019
|z 9780444642776
|w (OCoLC)1088921418
|
| 856 |
4 |
0 |
|3 ScienceDirect
|u https://www.sciencedirect.com/science/bookseries/00796468/58
|z Full Text via HEAL-Link
|
